Logo

Tm Bioscience to Trade on Toronto Stock Exchange

Apr 08, 2004

NEW YORK, April 8 (GenomeWeb News) - Tm Bioscience announced today that it will begin trading on the Toronto Stock Exchange on April 12 under the symbol "TMC."

 

"The move fulfills a major corporate objective management had set for this year," Greg Hines, Tm's president and CEO, said in a statement.

 

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.